FDA approves first drug for myelofibrosis
The U.S. Food and Drug Administration has approved Jakafi (ruxolitinb), the first drug approved to treat patients with the bone marrow disease myelofibrosis. Read more.
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
